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Summary  Infected  aortic  aneurysm  and  inﬂammatory  aortic  aneurysm  each  account  for  a
minor fraction  of  the  total  incidence  of  aortic  aneurysm  and  are  associated  with  periaor-
tic inﬂammation.  Despite  the  similarity,  infected  aortic  aneurysm  generally  shows  a  more
rapid change  in  clinical  condition,  leading  to  a  fatal  outcome;  in  addition,  delayed  diagno-
sis and  misuse  of  corticosteroid  or  immunosuppressing  drugs  may  lead  to  uncontrolled  growth
of microorganisms.  Therefore,  it  is  mandatory  that  detection  of  aortic  aneurysm  is  followed
by accurate  differential  diagnosis.  In  general,  infected  aortic  aneurysm  appears  usually  as  a
saccular form  aneurysm  with  nodularity,  irregular  conﬁguration;  however,  the  differential  diag-
nosis may  not  be  easy  sometimes  for  the  following  reasons:  (1)  symptoms,  such  as  abdominal
and/or back  pain  and  fever,  and  blood  test  abnormalities,  such  as  elevated  C-reactive  protein
and enhanced  erythrocyte  sedimentation  rate,  are  common  in  infected  aortic  aneurysm,  but
they are  not  found  infrequently  in  inﬂammatory  aortic  aneurysm;  (2)  some  inﬂammatory  aortic
aneurysms  are  immunoglobulin  (Ig)  G4-related,  but  not  all  of  them;  (3)  the  prevalence  of  IgG4
positivity  in  infected  aortic  aneurysm  has  not  been  well  investigated;  (4)  enhanced  uptake  of
18F-ﬂuorodeoxyglucose  (FDG)  by  18F-FDG-positron  emission  tomography  may  not  distinguish
between  inﬂammation  mediated  by  autoimmunity  and  that  mediated  by  microorganism  infec-
tion. Here  we  discuss  the  charac
of which  we  have  to  be  aware  b
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ntroduction
long  with  greater  life-expectancy,  the  prevalence  of  aortic
neurysm,  a  potently  life-threatening  disorder,  is  increasing
ecause  the  aging  process  promotes  aortic  remodeling.  A
pread  of  imaging  modalities,  such  as  computed  tomography
CT)  and  magnetic  resonance  imaging  (MRI),  may  facilitate
he  discovery  of  aortic  aneurysm,  which  may  sometimes  be
symptomatic,  during  a  medical  check-up  [1,2]. On  the  one
and,  inﬂammatory  aortic  aneurysm  represents  a  speciﬁc
ubset  of  aortic  aneurysm,  which  is  thought  to  be  caused
y  a  pathogenic  immuno-inﬂammatory  process,  occasionally
mmunoglobulin  G4  (IgG4)-related  [3],  and  corticosteroid
nd/or  immunosuppressive  therapies  may  be  effective.  On
he  other  hand,  for  infected  aortic  aneurysm,  another  subset
f  aortic  aneurysm,  early  and  timely  surgery  with  perioper-
tive  antimicrobial  treatment  is  thought  to  be  mandatory;
therwise,  the  outcome  is  in  general  not  favorable.  Differ-
nces  exist  between  these  two  forms  of  aortic  aneurysms;
owever,  there  are  certain  similarities  in  clinical  symptoms,
aboratory  tests,  and  ﬁndings  by  imaging  modalities,  which
ay  make  differential  diagnosis  difﬁcult.  In  this  mini  review,
e  discuss  these  two  forms  of  aortic  aneurysm,  inﬂamma-
ory  and  infected  aortic  aneurysms,  both  of  which  may  be
nder-recognized,  underdiagnosed,  and  sometimes  misdiag-
osed.
nfected aortic aneurysm and infected aortitis
revalence
fraction  of  this  disease  is  actually  caused  by  fungus  [8].
Considering  that  the  term  ‘mycotic  aneurysm’  was  initially
limited  to  the  development  of  infected  aneurysm  secondary
to  infective  endocarditis  [9],  this  terminology  may  lead  to
slight  confusion.  The  prevalence  of  infected  aortic  aneurysm
may  not  be  decreasing  recently,  and  it  is  considered  to
comprise  0.7—2.6%  of  all  cases  of  aortic  aneurysm  [10],
although  its  true  prevalence  is  unknown.  Infected  aneurysm
may  develop  from  a  hematogenous  spread  of  infection
from  microemboli  to  a  preexisting  aneurysm,  the  contigu-
ous  involvement  of  the  vessel  wall  from  an  adjacent  source
of  sepsis,  or  direct  infectious  inoculation  of  the  vessel  wall.
Atherogenic  risk  factors,  such  as  hypertension  and  diabetes,
may  be  present  as  predisposing  conditions  [11]; however,
infected  aneurysm  may  commonly  involve  parts  of  the  aorta
that  are  not  commonly  involved  by  atherosclerotic  aortic
aneurysm  [5];  about  70%  of  the  infected  aneurysms  were
found  to  be  located  in  the  thoracic  and  abdominal  aorta  at
or  above  the  renal  arteries  [12].
Clinical  features,  laboratory  abnormalities,  and
imaging
The  main  presenting  symptoms  are  fever  and  abdominal
and  severe  back,  abdominal,  or  thoracic  pain,  depending
on  the  location  of  the  aneurysm  [7],  although  some  patients
with  infected  aneurysm  may  be  asymptomatic  [12]. Blood
testing  shows  evidence  of  infection,  such  as  leukocytosis,
elevated  C-reactive  protein,  and  positive  blood  cultures.  In
addition  to  this  clinical  evidence  of  infection,  the  presence
of  periaortic  soft  tissue  inﬁltration,  as  demonstrated  by  CT
or  magnetic  resonance  angiography  (MRA)  may  lead  to  theince  ﬁrst  reported  by  Osler  in  1885  [4],  infected  aor-
ic  aneurysm  remains  a  life-threatening  condition  [5—7].
Infected’  aortic  aneurysm  is  sometimes  alternatively
ermed  ‘mycotic’  aortic  aneurysm;  however,  only  a  minor
d
s
f
miagnosis  of  infected  aortic  aneurysm  [12]. Although  ultra-
onography  may  not  be  a  reliable  initial  imaging  modality
or  the  diagnosis,  detection  of  gas  echoes  in  the  aortic  wall
ay  lead  to  suspected  infection  of  the  aortic  wall  [13].
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Figure  1  A  78-year-old  man  who  had  been  diagnosed  to  have  hypertension  and  hypertrophic  cardiomyopathy  was  referred  to  our
hospital because  of  high  fever  (40 ◦C)  and  abdominal  pain.  On  day  5  of  hospitalization,  Bacteroides  thetaiotaomicron  was  identiﬁed
in blood  culture.  (A—C)  Transverse  sections  of  computed  tomographic  (CT)  scanning  images.  (D)  Coronal  section  of  CT  image.  (A)  On
the day  of  admission.  (B)  5th  hospital  day.  (C  and  D)  12th  hospital  day.  The  diameter  of  the  aortic  aneurysm  showed  rapid  dilatation.
(E) Clinical  course  of  the  patient.  CMZ,  cefmetazole;  LVFX,  levoﬂoxacin;  IPM/CS,  imipenem/cilastatin;  MINO,  minocycline;  CRP,
t
i
r
a
dC-reactive protein;  WBC,  white  blood  cell.
Currently,  multidetector  CT  angiography  is  the  imag-
ing  modality  of  choice  for  the  evaluation  of  suspected
infected  aneurysms  [14]. Gallium  scanning  and  18F-
ﬂuorodeoxyglucose  positron  emission  tomography  (FDG-
PET)  may  be  used  to  evaluate  disease  activity  [15]. Infected
aortic  aneurysm  appears  as  a  focal,  contrast-enhancing
dilatation,  which  may  be  multilobulated.  A  mantle  sign-
like  appearance  may  be  present  in  infected  aortic  aneurysm
[16],  suggesting  that  this  sign  is  not  exclusive  to  inﬂamma-
tory  aortic  aneurysm  or  idiopathic  retroperitoneal  ﬁbrosis.
o
h
i
cThe mortality  in  infected  aortic  aneurysm  is  higher  than
hat  in  non-infected  aortic  aneurysm  [5].  A  bacterially
nfected  aorta  may  appear  to  be  within  the  normal-size
ange  in  the  initial  evaluation;  however,  dilatation  of  the
orta  may  progress  rapidly  over  months  [17]  or  even
ays  [15]  (Fig.  1),  leading  to  rupture  and  death  with-
ut  appropriate  diagnosis  and  treatment  [7].  On  the  other
and,  identiﬁcation  of  infective  microorganisms  and  clar-
ﬁcation  of  their  sensitivity  to  certain  antibiotics  provide
rucial  information  for  both  the  diagnosis  and  the  choice  of
126  N.  Ishizaka  et  al.
Figure  2  A  62-year-old  man  experienced  chest  discomfort  and  sustained  high  fever.  The  C-reactive  protein  level  was  elevated
(3.68 mg/dL),  but  the  IgG4  level  was  normal  (29.6  mg/dL).  Following  2  months  of  antimicrobial  therapy,  he  was  treated  surgi-
cally. Computed  tomography  of  arterial  phase  (A)  and  venous  phase  (B).  Periaortic  staining  was  apparent  in  the  venous  phase.  (C)
Hematoxylin-eosin  staining  of  the  aortic  section.  In  the  adventitia,  there  was  an  accumulation  of  lymphatic  cells,  which  were  mostly
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megative for  IgG4  (data  not  shown).  Original  magniﬁcation,  20
ot be  identiﬁed.
ntimicrobials.  Among  the  pathogens,  Salmonella, Staphy-
ococcus,  Campylobacter,  and  Streptococcus  species  have
een  identiﬁed  most  frequently  [18], but  other  microorgan-
sms  such  as  Escherichia  coli, Mycobacteria, and  Bacteroides
pecies  (Fig.  1)  have  been  reported.  The  pathogens  detected
ay  show  substantial  differences  according  to  the  region
5,6,10,19],  and  period  surveyed  [20,21].  On  the  other  hand,
acterial  identiﬁcation  may  not  always  be  possible  (Fig.  2),
ecause  of  difﬁculties  in  culture  or  prior  antibiotic  treat-
ent  [10]. Bennett  reported  that  blood  cultures  may  be
egative  in  as  many  as  47%  of  patients  with  infected  aor-
ic  aneurysm  in  a  paper  published  in  1967  [22]. In  addition,
derich  et  al.  have  reported  that  infective  orgasms  were
dentiﬁed  in  33  (77%)  of  43  patients  [5].  Furthermore,  Maeda
t  al.  reported  that  the  blood  culture  was  positive  only  in
individual  among  11  patients  with  infected  aortic  or  ileac
rtery  aneurysm  [20].
herapy
nfected  aortic  aneurysm  may  show  rapid  growth  in  size,
ccompanied  by  a  pseudoaneurysm  or  a  perforated  or  pene-
rated  aneurysm  [5],  therefore,  diagnostic  imaging  may  have
o  be  repeated  if  the  clinical  suspicion  persists  [23]. Non-  or
elayed  treatment  of  infected  aneurysm  often  leads  to  a
atal  outcome  due  to  fulminant  sepsis,  aorto-enteric  ﬁstula
ormation,  and  rupture  [14,24].
edical  management
urely  medical  management  may  be  often  inadequate
ecause  of  the  possibility  of  persistent  infection  and  sub-
equent  aneurysm  rupture.  The  conventional  strategy  for
reatment  is  therefore  prompt  surgical  treatment,  fol-
owed  by  long-term  suppressive  antibiotic  therapy.  Intensive
ntibiotic  therapy  that  is  started  perioperatively  and  con-
inued  for  a  prolonged  period  [7,25]  is  crucial  for  successful
reatment.  The  required  duration  of  antibiotics  has  not  been
ell  established,  however,  it  commonly  ranges  from  6  to  8
eeks  to  lifelong  treatment  [7].  Although  the  persistence
f  infection  greatly  affects  the  perioperative  outcome  [26],
hether  calming  down  of  the  infection  can  be  achieved
afely  may  depend  on  the  condition  of  each  patient.
v
a
a
respite  repeated  cultures,  the  causative  microorganism  could
urgical  management
urvival  is  clearly  dependent  on  the  state  of  rupture.  Thus,
imely  surgical  treatment  is  mandatory  for  the  management
f  infected  aortic  aneurysm;  however,  surgical  risk  and  peri-
perative  mortality  are  not  negligible  [7].  In  addition,  late
ostoperative  death  may  occur  due  to  existing  comorbidi-
ies.  Among  15  patients  with  infected  aortitis,  Luo  et  al.
eported  that,  in  addition  to  two  perioperative  deaths,  there
ere  two  late  deaths  due  to  brain  stem  hemorrhage  and  to
eart  failure  [27]. In  addition,  Moneta  et  al.  reported  that,
n  their  series  of  17  patients,  the  late  death  of  4  patients
ccurred  at  1.3—6.3  years  postoperatively,  in  addition  to
he  perioperative  death  of  4  patients  [28]. Furthermore,
üller  et  al.  reported  the  outcome  of  33  cases  of  infected
neurysm  of  either  the  aorta  or  the  iliac  arteriesaortic,
mong  which  12  patients  (36%)  died  perioperatively  from
ardiac,  respiratory,  or  infectious  reasons  [7].  In  Müller
t  al.’s  series,  survival  was  clearly  dependent  on  the  state
f  rupture.  The  mortality  associated  with  extraanatomic
econstruction  [20]  after  the  primary  infection  was  cured
as  reported  to  be  7%  [29], and  that  associated  with  in  situ
raft  placement  was14—36%  [7,14,30],  although  there  has
een  no  strict  controlled  trial.  Whether  endovascular  aortic
epair  (EVAR)  would  be  feasible  for  infected  aortic  aneurysm
as  been  discussed  in  several  previous  papers  [31]. At  the
urrent  moment,  however,  the  efﬁcacy  of  this  new  ther-
peutic  modality  should  be  analyzed  with  caution  because
on-removal  of  infected  nidi  may  be  aggravated  by  a  foreign
ody  [32].
nﬂammatory aortic aneurysm
revalence
nﬂammatory  aortic  aneurysms  present  a  minor  subgroup
ith  an  incidence  ranging  from  2.2%  to  18.1%  of  the  total
umber  of  abdominal  aortic  aneurysms  [33—35]. Inﬂam-
atory  abdominal  aortic  aneurysm  is  distinguished  as  a
ariant  of  atherosclerotic  aortic  aneurysm  by  a  thickened
neurysm  wall,  accompanied  by  a  dense  ﬁbrosis  involving
djacent  structures  such  as  the  duodenum,  ureter,  and  infe-
ior  vena  cava  [36]. Although  inﬂammatory  aortic  aneurysm
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is  seen  mostly  in  the  infrarenal  abdominal  aorta,  it  may
occur  in  the  ascending  and  descending  thoracic  aorta  and
aortic  arch  [37—39]. Patients  usually  present  at  a  younger
age  than  those  with  atherosclerotic  aortic  aneurysm  [40].
Male  sex  and  smoking  are  reported  to  be  strongly  associ-
ated  with  this  form  of  aortic  aneurysm.  Data  regarding  the
incidence  of  inﬂammatory  aortic  aneurysms  in  the  whole
population  are  lacking.  Considering  that  the  prevalence  of
newly  diagnosed  abdominal  aortic  aneurysm  was  reported
as  65  per  100,000  person-years  [41]  and  that  2—18%  of  cases
might  possess  inﬂammatory  features  [33—35], the  preva-
lence  of  inﬂammatory  aortic  aneurysm  might  be  comparable
or  slightly  higher  than  that  of  idiopathic  retroperitoneal
ﬁbrosis,  which  has  been  reported  to  have  an  incidence  of  0.1
per  100,000  person-years  [42]. It  should  be  noted,  however,
that  inﬂammatory  aortic  aneurysm,  as  well  as  idiopathic
retroperitoneal  ﬁbrosis,  which  has  similar  ﬁbromatosis-like
reactive  inﬂammation  associated  with  ﬁbrosis  but  also  aortic
dilatation  [43], may  be  unrecognized  and  thus  underdiag-
nosed  [44,45].
Clinical  features,  laboratory  abnormalities,  and
imaging
Clinical  symptoms  include  abdominal  or  back  pain,  weight
loss,  and  low  grade  fever  [40], which  are,  it  may  be  said,  sim-
ilar  to  those  of  infected  aortic  aneurysm.  Yin  et  al.  reported
that  among  11  patients  with  inﬂammatory  aortic  aneurysm,
abdominal  pain  was  present  in  10  (91%),  lumbar  pain  in  9
(82%),  and  fever  in  8  (72%)  [46]. These  symptoms  contrast
with  those  of  the  less-symptomatic  atherosclerotic  aortic
aneurysm  [46,47].  The  prevalence  of  heavy  cigarette  smok-
ing  is,  of  note,  very  high  among  patients  with  inﬂammatory
aortic  aneurysm  [48].
Elevated  inﬂammatory  markers,  such  as  erythrocyte  sed-
imentation  rate,  white  blood  cell  count,  and  C  reactive
protein,  are  commonly  observed  [49]. In  addition,  positiv-
ity  of  anti-nuclear  antibody  and  elevation  of  IgG4maybe
observed  in  inﬂammatory  aortic  aneurysm,  suggesting  the
role  of  autoimmunity  [3,49—51].  IgG4-related  systemic  dis-
ease  is  a  newly  recognized  disorder  that  may  manifest
as  inﬂammatory  abdominal  aortic  aneurysm  or  retroperi-
toneal  ﬁbrosis  [52]; therefore,  elevation  of  serum  IgG4
levels  and/or  inﬁltration  of  IgG4-positive  plasma  cells  in
the  periaortic  tissues  may  help  the  diagnosis  of  inﬂamma-
tory  aortic  aneurysm.  By  contrast,  Kasashima  et  al.  reported
that  only  about  half  of  inﬂammatory  aortic  aneurysm  cases
are  judged  to  be  IgG4-related;  however,  the  clinical  pic-
ture  does  not  seem  to  differ  substantially  between  the
IgG4-related  and  non-IgG4-related  forms  of  inﬂammatory
aortic  aneurysm  [53], indicating  that  this  disease  cannot  be
determined  solely  on  IgG4  positivity  and  that  it  may  be  a
heterogeneous  disease.
CT scanning  displays  the  aneurysm  and  the  thickened
aortic  wall  with  periaortic  inﬂammation  and  ﬁbrosis,  the
so-called  ‘‘mantle  sign’’  (Fig.  3).  Periaortic  enhancement
by  contrast  medium  in  CT  scanning  may,  however,  mimic
rupture,  acute  intramural  hematoma,  and  extravasation  of
contrast  —  ﬁndings  that  sometimes  require  careful  dissocia-
tion  from  impending  rupture  or  dissecting  aortic  aneurysm,
especially  in  the  presence  of  severe  abdominal  or  back  pain
(
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54]. FDG-PET  scanning  may  be  able  to  illustrate  the  active
nﬂammation  around  the  aortic  wall  [55]. Macroscopically,
he  appearance  of  white,  glistening,  perianeurysmal  ﬁbrosis
s  characteristic  of  inﬂammatory  aortic  aneurysm  [36,48].
herapy
edical  therapy
orticosteroids  [47,56]  and  immunosuppressive  agents,  such
s  methotrexate,  cyclophosphamide,  and  azathioprine  have
lso  been  reported  to  be  effective  [34], however,  the  ulti-
ate  efﬁcacy  of  the  anti-inﬂammatory  approach  has  not
een  proven  [47].
urgery
lthough  inﬂammatory  aortic  aneurysm  may  be  less  liable  to
upture  than  atherosclerotic  aneurysm  [57], open  surgical
epair  is  one  of  the  therapeutic  options  aimed  at  prevent-
ng  rupture.  Surgical  results  have  greatly  improved  over  the
ast  35  years  [58,59],  although  the  mortality  for  inﬂamma-
ory  aortic  aneurysm  may  remain  slightly  higher  than  that  for
therosclerotic  aortic  aneurysm.  Although  periaortic  inﬂam-
ation  can  be  improved  post-operatively,  it  may  show  no
hange  or  worsening  in  some  patients  [35].
ndovascular  aortic  repair
lthough  experience  of  the  treatment  of  inﬂammatory
ortic  aneurysm  with  EVAR  has  been  accumulating,  no  ran-
omized  controlled  trials  exist  comparing  open  surgical
epair  and  EVAR.  Paravastu  et  al.  reported  in  their  sys-
ematic  review  that  EVAR  is  associated  with  lower  1-year
ortality  as  compared  with  open  surgical  repair  [60]. On
he  other  hand,  both  treatments  led  to  regression  of  periaor-
ic  inﬂammation  (73%  in  the  open  surgical  repair  group  and
5%  in  the  EVAR  group).  On  the  other  hand,  secondary  inter-
ention  was  found  to  be  required  in  22%  of  patients  after
VAR.
The  periaortitis  seen  with  inﬂammatory  abdominal  aor-
ic  aneurysms  usually  resolves  after  repair  by  endovascular
echniques  such  as  open  surgical  repair;  however,  resolution
f  the  periaortic  ﬁbrosis  may  occur  less  often  after  EVAR
59].  Development  of  de  novo  retroperitoneal  ﬁbrosis  after
VAR  has  been  reported,  albeit  rarely,  to  occur  [61], and
VAR  may  not  offer  any  beneﬁts  for  hydronephrosis  [62].
VAR  appears  to  be  feasible  when  the  anatomical  features
re  appropriate  [59]; however,  open  surgical  repair  might
e  the  preferred  treatment,  especially  when  inﬂammatory
bdominal  aortic  aneurysm  is  complicated  by  hydronephro-
is.
ifferential diagnosis between infected and
nﬂammatory aortic aneurysms
s  discussed  above,  there  are  similarities  between  infected
nd  inﬂammatory  aortic  aneurysms  in  terms  of  their  clin-
cal  features  (e.g.  abdominal/back  pain),  laboratory  data
e.g.  increased  C-reactive  protein),  and  imaging  ﬁndings
e.g.  perianeurysmal  soft-tissue  mass).  In  addition  to  the
orta,  vessels  of  various  sizes,  including  vertebral,  coro-
ary,  and  iliac  arteries,  may  be  involved  in  inﬂammatory
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Figure  3  A  57-year-old  man  presented  with  repetitive  epigastralgia.  Coronal  sections  of  computed  tomography  (CT)  scanning
images. (A)  Dense  soft  tissue  surrounding  the  mildly  dilated  abdominal  aorta  can  be  observed.  (B)  3D  reconstruction  of  the  CT
images. Calciﬁcation  of  the  wall  of  the  aorta  and  common  and  internal  ileac  arteriesis  observed.  In  this  patient,  corticosteroid
therapy reduced  clinical  symptoms  and  periaortic  soft  tissue.  Serum  IgG4  level  was  not  elevated  in  this  case.  Details  in  this  case
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Iave been  reported  elsewhere  [77].
neurysm  [51,63,64]  and  infected  aneurysm  [65—67]. In
ddition,  similar  therapeutic  strategies  (e.g.  open  surgical
epair,  EVAR)  may  be  applied  to  these  two  different  clini-
al  conditions.  There  are,  however,  also  differences,  such
s  the  indications  for  medical  therapy  with  corticosteroid
r  antimicrobial  drugs,  speed  of  aneurysm  expansion,  and
erioperative  mortality.  Considering  that  periaortic  inﬂam-
ations  are  becoming  more  readily  and  reliably  discovered
y  CT  scanning  [68], the  necessity  for  a  differential  diagnosis
s  increasing.
maging
n  CT  scan,  infected  aortic  aneurysm  appears  usually  as
 saccular  form  aneurysm  with  nodularity,  irregular  con-
guration,  or  air  in  the  aortic  wall  [69], in  contrast  to
nﬂammatory  aortic  aneurysm,  which  typically  exhibits  a
usiform  morphology  [70], although  a  saccular  morphol-
gy  is  also  possible  [71]. Calciﬁcation  within  the  aneurysm
all  may  be  less  common  in  infected  aneurysm  [72],
lthough  it  can  be  present  (Figs.  1  and  2).  In  inﬂamma-
ory  aortic  aneurysm,  the  degree  of  calciﬁcation  in  the
ortic  wall  may  differ  according  to  the  case  [1,56,73].
ydronephrosis  may  occur  also  in  the  infected  aneurysm
74].
As  mentioned  above,  FDG-PET  is  a  useful  method  for
ssessing  the  active  inﬂammation  and  therapeutic  effective-
ess  in  patients  with  inﬂammatory  aortic  aneurysm  [75—77];
owever,  increased  FDG-uptake  may  also  be  demonstrated
n  infected  aortic  aneurysm  [15,78]  as  well  as  in  other  types
f  large-vessel  inﬂammation  [79], such  as  Takayasu  arteritis
80]. The  ability  of  FDG-PET  to  provide  a  differential  diag-
osis  between  inﬂammatory  and  infected  aneurysm  may,
herefore,  be  limited.  The  value  of  examining  FDG  uptake
or  the  assessment  of  aneurysm  wall  strength,  rupture  risk
h
a
d
n81], and  effect  of  medical  interventions  needs  future  stud-
es  [82].
olecular  diagnosis
t  has  been  reported  that  broad-range  polymerase  chain
eaction  (PCR)  ampliﬁcation  targeting  the  bacterial  16S
RNA  gene,  followed  by  direct  sequencing  may  provide  a
rompt  and  facilitated  identiﬁcation  of  infected  bacteria  in
ulture  negative  cases  [83—86].
gG4
n  the  one  hand,  elevation  of  serum  IgG4  and/or  periaortic
nﬁltration  of  IgG4-positive  lymphocytes  may  be  observed
n  inﬂammatory  aortic  aneurysm  [87]. On  the  other  hand,
erum  IgG4  may  be  elevated  in  a  wide  variety  of  disor-
ers,  which  may  include  so-called  ‘‘IgG4-related  disease’’,
uch  as  autoimmune  pancreatitis,  Mikulicz’s  disease,  and
iedel’s  thyroiditis  [88]. As  discussed  above,  only  about
alf  of  inﬂammatory  aortic  aneurysm  cases  may  show  IgG4-
ositivity  [3].  Of  note,  Kanemitsu  et  al.  have  recently
eported  inﬁltration  of  numerous  IgG4-positive  plasma  cells
n  the  thickened  periarterial  tissue  of  the  aorta  with
nterobacter  infection  [89], suggesting  the  possibility  that
gG4-related  immune  inﬂammation  might  also  play  a  role
n  infected  aortitis  and  that  both  inﬂammatory  and  infected
ortic  aneurysm  may  coexist.  Further  studies  should  address
he  incidence  of  IgG4-positivity  in  infected  aortic  aneurysm,
or  which  little  information  is  currently  available.  Total
gG  may  also  be  elevated  in  inﬂammatory  aortic  aneurysm;
owever,  it  may  also  be  elevated  in  atherosclerotic  aortic
neurysm,  and  thus  may  be  a  less  potent  biomarker  for  the
iscrimination  of  inﬂammatory  aortic  aneurysm  from  the
on-inﬂammatory  form  [53].
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Other  biomarkers
As  discussed  above,  inﬂammatory  markers,  such  as  ery-
throcyte  sedimentation  rate  and  C-reactive  protein,  may
be  elevated  in  both  inﬂammatory  and  infected  aortic
aneurysms.  Procalcitonin,  a  polypeptide  comprising  113
amino  acids,  is  gathering  increasing  attention  because  of
strong  correlation  between  procalcitonin  concentration  and
extent  and  severity  of  bacterial  infections  [90]. In  the  case
of  infected  aortic  aneurysm  we  had  experienced  (Fig.  1),
serum  procalcitonin  level  at  admission  was  1.05  ng/mL,  a
level  that  was  suggestive  of  bacterial  infection.  Procalci-
tonin  is  produced  ubiquitously  by  endotoxin  or  mediators
released  in  response  to  bacterial  infections;  thus,  utility
of  inﬂammatory  cytokines  [92]  and  procalcitonin  for  dis-
criminating  inﬂammatory  IgG4-related,  or  non-IgG4-related,
aortic  aneurysm  from  infected  aortic  aneurysm  should  be
assessed  in  future  studies.
We  recently  reported  that  the  serum  sIL-2R  level  was
elevated  in  6  (75%)  of  8  patients  with  chronic  periaorti-
tis  [91], suggesting  that  sIL-2R  may  be  another  candidate
biomarker  for  discriminating  inﬂammatory  from  infected
aortic  aneurysm;  again,  however,  little  is  known  about  sIL-2R
levels  in  infected  aneurysm.  New  biomarkers  that  speciﬁ-
cally  identify  the  inﬂammatory  (or  infected)  aortic  aneurysm
are  now  under  surveillance.
Conclusions
Here  we  have  brieﬂy  summarized  the  current  understand-
ing  of  both  infected  and  inﬂammatory  aortic  aneurysm,
and  discussed  the  potential  uncertainty  for  a  differential
diagnosis.  These  two  clinical  entities  possess  various  simi-
larities  in  clinical  manifestation,  biomarkers,  CT,  MRI,  and
radionucleotide  imaging.  It  is  considered  that  incorrect
administration  of  immunosuppressing  agents  in  infected  aor-
tic  aneurysm  would  be  hazardous  [93]  and  delayed  diagnosis
may  lead  to  uncontrolled  growth  of  microorganisms.  Caution
should  be  taken  to  avoid  the  easy  usage  of  corticosteroid  or
immunosuppressing  drugs  before  the  full  diagnosis  is  estab-
lished.
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